US Patent 11033635 Antibody-STING agonist conjugates and their use in immunotherapy
All edits
Edits on 12 Dec, 2023
Golden AI
Edits made to:
Article (+218 characters)
Article
Patent abstract
The present disclosure relates to, among other things, antibody-drug conjugates comprising a STING agonist cyclic di-nucleotide conjugated to an antibody, preparation methods therefor, and uses therefor.
Edits on 23 May, 2023
Golden AI
Edits made to:
Infobox (-1 properties)
Infobox
Official Website
Edits on 29 Apr, 2023
Golden AI
Infobox
Edits on 29 Mar, 2023
Golden AI
Infobox
Is a
Patent Jurisdiction
Patent Number
110336350
Date of Patent
June 15, 2021
0Patent Application Number
169338450
Date Filed
July 20, 2020
0Official Website
Patent Citations
Patent Primary Examiner
Golden AI
Infobox
Patent Citations
Edits on 26 Mar, 2023
Golden AI
Infobox
Patent Citations
Edits on 28 Sep, 2022
Golden AI
Infobox
Patent Citations
Edits on 27 Sep, 2022
Golden AI
Infobox
Patent Citations
Golden AI
Infobox
Edits on 25 Sep, 2022
Golden AI
Infobox
Patent Citations
Edits on 23 Sep, 2022
Golden AI
Infobox
Is a
Patent Jurisdiction
Patent Number
110336350
Date of Patent
June 15, 2021
0Patent Application Number
169338450
Date Filed
July 20, 2020
0Official Website
Patent Citations
Patent Primary Examiner
Edits on 6 Jun, 2022
Golden AI
Edits made to:
Infobox (+1 properties)
Infobox
Website URL
Edits on 12 Feb, 2022
Golden AI
Edits made to:
Infobox (+12 properties)
US Patent 11033635 Antibody-STING agonist conjugates and their use in immunotherapy
Infobox
Is a
Patent jurisdiction
Patent number
11033635
Date of patent
June 15, 2021
Patent application number
16933845
Date Filed
July 20, 2020
Patent citations
Patent primary examiner
Find more entities like US Patent 11033635 Antibody-STING agonist conjugates and their use in immunotherapy
Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.
